MedTrace Logo

Evaluation of BIS for Quantification of Lymphedema

NCT01544335 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2024-06-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether measuring the fluid in your arms using Bioimpedance Spectroscopy is as effective at detecting and monitoring lymphedema as measurements with the Perometer. The investigators will also evaluate any symptoms you may experience in your arms during and after treatment for breast cancer with a questionnaire.

Conditions

Interventions

OTHER

Bioimpedance Spectroscopy

BIS used to measure fluid in arm

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01544335 on ClinicalTrials.gov